Biodiversity and Physiological Characteristics of Novel Faecalibacterium prausnitzii Strains Isolated from Human Feces
Open Access
- 26 January 2022
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 10 (2), 297
- https://doi.org/10.3390/microorganisms10020297
Abstract
Faecalibacterium prausnitzii is prevalent in the human gut and is a potential candidate for next-generation probiotics (NGPs) or biotherapeutics. However, the biodiversity and physiological characteristics of Faecalibacterium prausnitzii remain unclear. This study isolated 26 novel F. prausnitzii strains from human feces using a combination of negative screening and prime-specific PCR amplification (NSPA). Based on a 16S rRNA gene analysis, F. prausnitzii strains can be classified into two main phylogroups (phylogroups I and II), which were further clustered into five subgroups (I-A, II-B, II-C, II-D, and II-E). The ultrastructure, colony morphology, growth performance, and short-chain fatty acids (SCFAs)-producing ability were found to be variable among these F. prausnitzii isolates. The optimal pH for the isolates growth ranged between 6.0 and 7.0, while most isolates were inhibited by 0.1% of bile salts. Antimicrobial resistance profiles showed that all F. prausnitzii isolates were susceptible to vancomycin, whereas >80% were kanamycin and gentamicin resistant. Additionally, all strains can utilize maltose, cellulose, and fructose but not xylose, sorbose, and 2′-FL. Overall, our work provides new insights into the biodiversity and physiological characteristics of F. prausnitzii, as well as the choices of strains suitable for NGPs.Keywords
Funding Information
- National Natural Science Foundation of China (No. 31820103010)
This publication has 46 references indexed in Scilit:
- Ecology and metabolism of the beneficial intestinal commensal bacteriumFaecalibacterium prausnitziiGut Microbes, 2014
- The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibitionProceedings of the National Academy of Sciences of the United States of America, 2014
- A decrease of the butyrate-producing speciesRoseburia hominisandFaecalibacterium prausnitziidefines dysbiosis in patients with ulcerative colitisGut, 2013
- The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolismJournal of Lipid Research, 2013
- Faecalibacterium prausnitzii and human intestinal healthCurrent Opinion in Microbiology, 2013
- An Extremely Simple and Effective Colony PCR Procedure for Bacteria, Yeasts, and MicroalgaeApplied Biochemistry and Biotechnology, 2012
- Cultured Representatives of Two Major Phylogroups of Human Colonic Faecalibacterium prausnitzii Can Utilize Pectin, Uronic Acids, and Host-Derived Substrates for GrowthApplied and Environmental Microbiology, 2012
- Assessment of Bacterial Antibiotic Resistance Transfer in the GutInternational Journal of Microbiology, 2011
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patientsProceedings of the National Academy of Sciences of the United States of America, 2008
- Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. novInternational Journal of Systematic and Evolutionary Microbiology, 2002